Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1997-7-28
|
pubmed:abstractText |
Serum selenium levels were determined cross-sectionally in 57 HIV-infected patients who were classified according to the Centers for Disease Control (CDC) 1993 classification system. Mean serum selenium levels were lower in CDC stage II (58.7 +/- 12.2 micrograms/L; p < 0.01; n = 18) and stage III (47.6 +/- 11.3 micrograms/L; p < 0.01; n = 19) HIV-infected patients, than in healthy subjects (80.6 +/- 9.6 micrograms/L; n = 48) and stage I patients (73.6 +/- 16.5 micrograms/L; n = 20). Serum selenium levels were positively correlated with CD4 count, CD4/8 ratio, hematocrit, and serum albumin (r = 0.42; r = 0.39; r = 0.48; and r = 0.45; p < 0.01, respectively) and inversely with serum levels of thymidine kinase (r = -0.49; p < 0.01; n = 49) and beta 2-microglobulin (r = -0.46; p < 0.001; n = 49). In addition, serum selenium levels in 20 randomly selected AIDS-free individuals (CDC I: n = 10; CDC II: n = 10) were inversely correlated with serum concentrations of interleukin-8 (IL-8) and soluble tumor necrosis factor receptors (sTNFR) types I and II. There was no correlation with serum immuneglobulin A and total serum protein levels. The results show that the progressive deprivation of serum selenium in HIV-infection is associated with loss of CD(4+)-cells and with increased levels of markers of disease progression and inflammatory response.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-8,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Selenium,
http://linkedlifedata.com/resource/pubmed/chemical/Thymidine Kinase,
http://linkedlifedata.com/resource/pubmed/chemical/beta 2-Microglobulin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0163-4984
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
31-41
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9152510-Adult,
pubmed-meshheading:9152510-Biological Markers,
pubmed-meshheading:9152510-CD4 Lymphocyte Count,
pubmed-meshheading:9152510-CD4-CD8 Ratio,
pubmed-meshheading:9152510-Case-Control Studies,
pubmed-meshheading:9152510-Female,
pubmed-meshheading:9152510-HIV Infections,
pubmed-meshheading:9152510-HIV-1,
pubmed-meshheading:9152510-Humans,
pubmed-meshheading:9152510-Inflammation,
pubmed-meshheading:9152510-Interleukin-8,
pubmed-meshheading:9152510-Male,
pubmed-meshheading:9152510-Middle Aged,
pubmed-meshheading:9152510-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:9152510-Selenium,
pubmed-meshheading:9152510-Thymidine Kinase,
pubmed-meshheading:9152510-beta 2-Microglobulin
|
pubmed:year |
1997
|
pubmed:articleTitle |
Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection.
|
pubmed:affiliation |
Department of General Internal Medicine, University of Bonn, Germany.
|
pubmed:publicationType |
Journal Article
|